相关实验视频
Updated: Jan 7, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.9K
基于脂质的纳米结构在神经疾病的有针对性的管理:一个全面的审查
Mridul Guleria1, Akanksha Kamble2, Mitali Upadhyay3
1Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India.
International journal of pharmaceutics
|December 26, 2025
概括
淋化脂质纳米载体提供了一种稳定,有效的方法,用于鼻至脑药物输送,绕过神经障碍. 这些先进的系统在治疗中枢神经系统 (CNS) 疾病方面表现有前途.
科学领域:
- *纳米技术和制药科学 *纳米技术和制药科学
- *神经科学与药物输送
背景情况:
- *由于复杂的病理和血脑屏障 (BBB),神经系统疾病对健康构成重大挑战.
- * 非侵入性鼻至脑输送提供了一种规避中枢神经系统障碍的策略.
- * 基于脂质的纳米结构 (SLN,NLC,脂质体) 由于生物相容性和广泛的封装能力,正在探索中枢神经系统疗法.
研究的目的:
- *审查针对中枢神经系统 (CNS) 药物输送的化脂基纳米载体的进展.
- * 总结鼻到脑的运输机制,配方策略和固化技术.
- *强调临床进展,挑战和未来的前景.
主要方法:
- * 关于用于中枢神经系统的基于脂质的纳米载体的科学文献的综述.
- *冷化和其他固化技术 (例如喷雾干燥) 的分析.
- * 检查运输机制,配方策略和表面修改以实现有针对性的交付.
主要成果:
- *冷化显著提高了脂质纳米载体的结构完整性,储存稳定性和可用性.
- * 这些载体表现出改善的粘膜粘附性,防腐保护,以及持续/响应性药物释放.
- *表面修改提高了准效率,取得了显著的临床进展和专利开发.
结论:
- *化脂基纳米结构代表了中枢神经系统治疗的多功能和有前途的平台.
- *需要进一步的研究,以克服扩展,安全和监管障碍等挑战.
- *未来的开发重点是混合,刺激响应和精确向系统,用于先进的神经药物输送.
相关概念视频
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503

